Drug Houses of Australia was an Australian public company established in 1936 as an amalgamation of seven Australian pharmaceutical companies, including Felton Grimwade & Co and A. M. Bickford & Sons. In 1970, DHA was taken over by the British bank Slater Walker. In September 2006, the Australian company was sold to Strides Arcolab through a share purchase agreement with Haw Par Healthcare Limited, Singapore, for approximately SGD$19.7 million. Drug Houses of Australia (Asia) Pte Ltd is now a leading manufacturer of generic pharmaceutics and Chinese proprietary medicine (CPM) based in Jurong, Singapore; and is a subsidiary of Strides Arcolab that is listed on both the Bombay and National stock exchanges in India.
References
External links "Home page". Drug Houses of Australia (Asia) Pte Ltd. Singapore. Archived from the original on 5 December 2006. Strides Arcolab website Haw Par website